UBS AM’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $1.03M | Buy |
|
|||||
|
2025
Q1 | $1.08M | Buy |
|
|||||
|
2024
Q4 | $616K | Sell |
|
|||||
|
2024
Q3 | $850K | Sell |
|
|||||
|
2024
Q2 | $686K | Buy |
|
|||||
|
2024
Q1 | $374K | Sell |
|
|||||
|
2023
Q4 | $719K | Buy |
|
|||||
|
2023
Q3 | $582K | Sell |
|
|||||
|
2023
Q2 | $784K | Hold |
|
|||||
|
2023
Q1 | $784K | Sell |
|
|||||
|
2022
Q4 | $2.89M | Sell |
|
|||||
|
2022
Q3 | $25.8M | Buy |
|
|||||
|
2022
Q2 | $30.4M | Buy |
|
|||||
|
2022
Q1 | $34.9M | Buy |
|
|||||
|
2021
Q4 | $49.2M | Buy |
|
|||||
|
2021
Q3 | $65.6M | Buy |
|
|||||
|
2021
Q2 | $61.5M | Sell |
|
|||||
|
2021
Q1 | $66.5M | Buy |
|
|||||
|
2020
Q4 | $48.3M | Buy |
|
|||||
|
2020
Q3 | $37.2M | Buy |
|
|||||
|
2020
Q2 | $23.7M | Sell |
|
|||||
|
2020
Q1 | $15.7M | Buy |
|
|||||
|
2019
Q4 | $19.8M | Buy |
|
|||||
|
2019
Q3 | $14M | Sell |
|
|||||
|
2019
Q2 | $14.4M | Buy |
|
|||||
|
2019
Q1 | $14.7M | Buy |
|
|||||
|
2018
Q4 | $14.5M | Buy |
|
|||||
|
2018
Q3 | $896K | Buy |
|
|||||
|
2018
Q2 | $20K | Buy |
|